RC48-ADC in HER2-low Advanced Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Disitamab vedotin
Sponsor: RenJi Hospital